SRH Wald-Klinikum Gera GmbH
2 clinical trials · Sponsor
◉ Watch SRH Wald-Klinikum Gera GmbH
| Record | Firm | Date |
|---|---|---|
| Surgical or Radiotherapeutic Intervention Concerning Large Singular Stable to Progressive Metastases in Patients With BRAFV600-mutated Melanoma Receiving Treatment With Encorafenib + Binimetinib (NCT07092410) | SRH Wald-Klinikum Gera GmbH | 2025-08-01 |
Track SRH Wald-Klinikum Gera GmbH automatically
Every clearance here is in the API, with alerts when new ones post.